Show simple item record

dc.contributor.authorRaben, D
dc.contributor.authorFaivre-Finn, Corinne
dc.contributor.authorSpigel, D
dc.contributor.authorDaniel, D
dc.contributor.authorVillegas, A
dc.contributor.authorVincente, D
dc.contributor.authorHui, R
dc.contributor.authorCarpeno, J
dc.contributor.authorMurakami, S
dc.contributor.authorPaz-Ares, L
dc.contributor.authorOzguroglu, M
dc.contributor.authorKurata, T
dc.contributor.authorChiappori, A
dc.contributor.authorLee, K
dc.contributor.authorde Wit, M
dc.contributor.authorPoole, L
dc.contributor.authorWadsworth, C
dc.contributor.authorDennis, P
dc.contributor.authorAntonia, S
dc.date.accessioned2019-01-10T13:02:06Z
dc.date.available2019-01-10T13:02:06Z
dc.date.issued2018en
dc.identifier.citationRaben D, Faivre-Finn C, Spigel D, Daniel D, Villegas A, Vincente D, et al. PACIFIC: Overall survival with durvalumab versus placebo after chemoradiotherapy in stage III NSCLC. Int J Radiat Oncol Biol Phys. 2018;102(5):1607-8.en
dc.identifier.urihttp://hdl.handle.net/10541/621465
dc.language.isoenen
dc.titlePACIFIC: Overall survival with durvalumab versus placebo after chemoradiotherapy in stage III NSCLCen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentUniversity of Colorado Cancer Center, Aurora, COen
dc.identifier.journalInt J Radiat Oncol Biol Physen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record